Literature DB >> 18387977

Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia.

Francesco Forconi1, Elisa Sozzi, Davide Rossi, Surinder S Sahota, Teresa Amato, Donatella Raspadori, Livio Trentin, Lorenzo Leoncini, Gianluca Gaidano, Francesco Lauria.   

Abstract

BACKGROUND: We previously reported ongoing mutational and isotype switch events in the immunoglobulin (Ig) heavy chain (H) locus in hairy cell leukemia. Those analyses raised questions on the incidence and type of selective influences occurring on the tumor B-cell receptor of hairy cell leukemia. DESIGN AND METHODS: To further investigate this issue, we examined the full IGH and kappa and lambda light chains (IGkappa and IGlambda) variable and constant region transcripts expressed in a large cohort of patients with hairy cell leukemia (n=88).
RESULTS: Multiple IgH isotypes were expressed in 46/56 (82%) cases of hairy cell leukemia. Comparison of tumor with normal B-cell repertoires revealed preferential usage of IGHV3-21, IGHV3-30 and IGHV3-33 in hairy cell leukemia (p=0.001, p=0.003 and p=0.001, respectively). Light chain analysis demonstrated preferential Igl use with an inverted IGk:IGl ratio (0.7:1) and universal usage of IGLJ3. Analysis of LCDR3 junctions revealed highly homologous motifs in 40% of IGL. Parallel analysis of IGH and IGL showed selective pairing of IGHV3-21/30/33 segments to specific LCDR3-J3 subsets (p=0.008). Of 40 cases of hairy cell leukemia, 38 had mutated IGHV and/or IGK/LV, with variations in 13/13 cloned cases, while two had 100% unmutated IGHV and IGK/LV.
CONCLUSIONS: Overall, biased IGV usage, preference for Iglambda with universal IGLJ3 usage and a high incidence of LCDR3 homologous motifs suggest selective influences on the B-cell receptor of hairy cell leukemia. Ongoing mutations and isotype switching suggest that influences occur on the tumor B-cell receptor at ectopic sites.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18387977     DOI: 10.3324/haematol.12282

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  13 in total

1.  Evolutionary redefinition of immunoglobulin light chain isotypes in tetrapods using molecular markers.

Authors:  Sabyasachi Das; Nikolas Nikolaidis; Jan Klein; Masatoshi Nei
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-21       Impact factor: 11.205

2.  Evidence of canonical somatic hypermutation in hairy cell leukemia.

Authors:  Evgeny Arons; Laura Roth; Jeffrey Sapolsky; Tara Suntum; Maryalice Stetler-Stevenson; Robert J Kreitman
Journal:  Blood       Date:  2011-03-02       Impact factor: 22.113

3.  Molecular variant of hairy cell leukemia with poor prognosis.

Authors:  Evgeny Arons; Robert J Kreitman
Journal:  Leuk Lymphoma       Date:  2011-06

Review 4.  The microenvironment in hairy cell leukemia: pathways and potential therapeutic targets.

Authors:  Jan A Burger; Mariela Sivina; Farhad Ravandi
Journal:  Leuk Lymphoma       Date:  2011-03-25

5.  Genome-wide promoter methylation of hairy cell leukemia.

Authors:  Alberto J Arribas; Andrea Rinaldi; Giorgia Chiodin; Ivo Kwee; Afua Adjeiwaa Mensah; Luciano Cascione; Davide Rossi; Meena Kanduri; Richard Rosenquist; Emanuele Zucca; Peter W Johnson; Gianluca Gaidano; Christopher C Oakes; Francesco Bertoni; Francesco Forconi
Journal:  Blood Adv       Date:  2019-02-12

6.  Class II human leucocyte antigen DRB1*11 in hairy cell leukaemia patients with and without haemolytic uraemic syndrome.

Authors:  Evgeny Arons; Sharon Adams; David J Venzon; Ira Pastan; Robert J Kreitman
Journal:  Br J Haematol       Date:  2014-06-13       Impact factor: 6.998

Review 7.  How I treat hairy cell leukemia.

Authors:  Michael R Grever
Journal:  Blood       Date:  2009-10-20       Impact factor: 22.113

8.  VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

Authors:  Evgeny Arons; Tara Suntum; Maryalice Stetler-Stevenson; Robert J Kreitman
Journal:  Blood       Date:  2009-09-10       Impact factor: 22.113

9.  IGK with conserved IGΚV/IGΚJ repertoire is expressed in acute myeloid leukemia and promotes leukemic cell migration.

Authors:  Chong Wang; Miaoran Xia; Xiaoping Sun; Zhiqiao He; Fanlei Hu; Lei Chen; Carlos E Bueso-Ramos; Xiaoyan Qiu; C Cameron Yin
Journal:  Oncotarget       Date:  2015-11-17

10.  Significant Differences in Physicochemical Properties of Human Immunoglobulin Kappa and Lambda CDR3 Regions.

Authors:  Catherine L Townsend; Julie M J Laffy; Yu-Chang Bryan Wu; Joselli Silva O'Hare; Victoria Martin; David Kipling; Franca Fraternali; Deborah K Dunn-Walters
Journal:  Front Immunol       Date:  2016-09-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.